home / stock / clsd / clsd news

CLSD News and Press, Clearside Biomedical Inc. From 05/08/24

Stock Information
Company Name: Clearside Biomedical Inc.
Stock Symbol: CLSD
Market: NASDAQ
Website: clearsidebio.com
Menu
CLSD CLSD Quote CLSD Short CLSD News CLSD Articles CLSD Message Board
Get CLSD Alerts

News, Short Squeeze, Breakout and More Instantly...
CLSD - Clearside Biomedical to Participate in Fireside Chat at the Citizens JMP Life Sciences Conference

ALPHARETTA, Ga., May 08, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS ® ), announced today that George Lasezkay, Pharm.D., J.D., ...
CLSD - Clearside Biomedical to Report First Quarter 2024 Financial Results and Provide Corporate Update on Thursday, May 9, 2024

ALPHARETTA, Ga., April 30, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS ® ), announced today that its first quarter 2024 financia...

CLSD - Clearside Biomedical Appoints Seasoned Biotechnology Executive Anthony S. Gibney to its Board of Directors

ALPHARETTA, Ga., April 16, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS ® ), announced today that Anthony S. Gibney has been appo...

CLSD - Clearside Biomedical to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference

ALPHARETTA, Ga., April 02, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS ® ), announced today that George Lasezkay, Pharm.D., J.D....
CLSD - Clearside Biomedical appoints Chong as CMO

2024-03-18 13:56:57 ET More on Clearside Biomedical Clearside Biomedical, Inc. (CLSD) Q4 2023 Earnings Call Transcript Clearside to sell 11.11M shares at $1.35 in registered direct offering Seeking Alpha’s Quant Rating on Clearside Biomedical Historica...

CLSD - Clearside Biomedical Appoints Victor Chong, M.D., MBA as Chief Medical Officer

ALPHARETTA, Ga., March 18, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS ® ), announced today that Victor Chong, M.D., MBA was app...

CLSD - Clearside Biomedical, Inc. (CLSD) Q4 2023 Earnings Call Transcript

2024-03-13 00:47:04 ET Clearside Biomedical, Inc. (CLSD) Q4 2023 Earnings Conference Call March 12, 2022, 04:30 PM ET Company Participants Jenny Kobin - IR George Lasezkay - CEO Charlie Deignan - CFO Conference Call Participants Annabel Samimy - Stife...
CLSD - Clearside Biomedical GAAP EPS of -$0.08 beats by $0.01, revenue of $6.35M beats by $2.11M

2024-03-12 16:06:52 ET More on Clearside Biomedical Clearside to sell 11.11M shares at $1.35 in registered direct offering Clearside Biomedical reports progress in ODYSSEY Phase 2b trial of CLS-AX Seeking Alpha’s Quant Rating on Clearside Biomedical Hi...

CLSD - Clearside Biomedical Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

- Phase 2b ODYSSEY Wet AMD Trial Remains on Track with Topline Data Expected in Q3 2024 - - Partner Programs Continue to Report Positive Clinical Data Utilizing SCS Microinjector ® - - Strengthened Capital Position from Registered Direct Equity Offering and Recent S...

CLSD - Expected US Company Earnings on Tuesday, March 12th, 2024

Koninklijke KPN NV (KKPNF) is expected to report for Q4 2023 ECA Marcellus Trust I Unit (ECTM) is expected to report for Q4 2023 San Juan Basin Royalty Trust (SJT) is expected to report for Q4 2023 Avenir Wellness Solutions Inc (AVRW) is expected to report for Q4 2023 Carmell Corp...
Previous 10 Next 10